Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Central Nervous System Neoplasms 8Brain Neoplasms 5Astrocytoma 5Medulloblastoma 4Oligodendroglioma 3Glioma 3Glioblastoma 3Spinal Cord Neoplasms 1Optic Nerve Glioma 1Lymphoma, AIDS-Related 1Gliosarcoma 1Cognition Disorders 1

Interventions

Temozolomide 3Vincristine 2Radiotherapy 2Carboplatin 2lonafarnib 1etoposide phosphate 1emvododstat 1Valproic Acid 1Thiotepa 1Radiation 1Peripheral Blood Stem Cell Transplantation 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Lomustine 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Spinal Cord Neoplasms × Lomustine × Clear all
NCT00100802 2023-02-15

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Children's Oncology Group

Phase 2 Completed
118 enrolled 8 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡